These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20528079)

  • 21. Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
    Brain Pathol; 2014 Jan; 24(1):33-44. PubMed ID: 23802663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates.
    Gao FJ; Klinedinst D; Fernandez FX; Cheng B; Savonenko A; Devenney B; Li Y; Wu D; Pomper MG; Reeves RH
    Acta Neuropathol Commun; 2021 Aug; 9(1):137. PubMed ID: 34399854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal choline supplementation lessens the behavioral dysfunction produced by developmental manganese exposure in a rodent model of ADHD.
    Howard SL; Beaudin SA; Strupp BJ; Smith DR
    bioRxiv; 2023 Oct; ():. PubMed ID: 37425833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
    Lysenko LV; Kim J; Henry C; Tyrtyshnaia A; Kohnz RA; Madamba F; Simon GM; Kleschevnikova NE; Nomura DK; Ezekowitz RA; Kleschevnikov AM
    PLoS One; 2014; 9(12):e114521. PubMed ID: 25474204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal Choline Supplementation during High-Fat Feeding Improves Long-Term Blood Glucose Control in Male Mouse Offspring.
    Korsmo HW; Edwards K; Dave B; Jack-Roberts C; Yu H; Saxena A; Salvador M; Dembitzer M; Phagoora J; Jiang X
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31947955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
    Lockrow J; Prakasam A; Huang P; Bimonte-Nelson H; Sambamurti K; Granholm AC
    Exp Neurol; 2009 Apr; 216(2):278-89. PubMed ID: 19135442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial.
    Bahnfleth CL; Strupp BJ; Caudill MA; Canfield RL
    FASEB J; 2022 Jan; 36(1):e22054. PubMed ID: 34962672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
    Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
    Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells.
    Rachubinski AL; Maclean KN; Evans JR; Bjugstad KB
    Exp Gerontol; 2012 Sep; 47(9):723-33. PubMed ID: 22776132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased systolic blood pressure in rat offspring following a maternal low-protein diet is normalized by maternal dietary choline supplementation.
    Bai SY; Briggs DI; Vickers MH
    J Dev Orig Health Dis; 2012 Oct; 3(5):342-9. PubMed ID: 25102263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.
    Hunter CL; Bimonte-Nelson HA; Nelson M; Eckman CB; Granholm AC
    Neurobiol Aging; 2004 Aug; 25(7):873-84. PubMed ID: 15212841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.
    Hunter CL; Bimonte HA; Granholm AC
    Behav Brain Res; 2003 Jan; 138(2):121-31. PubMed ID: 12527443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: a mouse model of Down syndrome and Alzheimer's disease.
    Driscoll LL; Carroll JC; Moon J; Crnic LS; Levitsky DA; Strupp BJ
    Behav Neurosci; 2004 Dec; 118(6):1196-205. PubMed ID: 15598129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer's disease.
    Chartampila E; Elayouby KS; Leary P; LaFrancois JJ; Alcantara-Gonzalez D; Jain S; Gerencer K; Botterill JJ; Ginsberg SD; Scharfman HE
    Elife; 2024 Jun; 12():. PubMed ID: 38904658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.